Not Medicare Enrolled
Dr. Marcus Porcelli, MD
Hematology & Oncology · Somerset, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Porcelli from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Porcelli?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Porcelli
Dr. Marcus Porcelli is a hematology & oncology specialist in Somerset, NJ, with 20 years of NPI registration. Based on federal Medicare data, Dr. Porcelli performed 122,999 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Porcelli received a total of $3,465 from 50 pharmaceutical and/or device companies across 145 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Porcelli is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years of NPI registration
▲ Top 6% volume in NJ
$3,465 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗122,999
Medicare services
Top 6% in NJ for hematology & oncology
Not available
Unique patients (not deduplicated)
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Injectafer) An intravenous injection of ferric carboxymaltose, an iron replacement medication. |
85,500 | $1 | $3 |
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
10,201 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,300 | $2 | $10 |
| Pembrolizumab injection (Keytruda) | 6,800 | $43 | $161 |
| Denosumab injection (Prolia/Xgeva) | 3,120 | $18 | $67 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
1,590 | $36 | $137 |
| Iron infusion (Monoferric) | 1,200 | $16 | $63 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,024 | $0 | $0 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
760 | $8 | $31 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
716 | $76 | $298 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
675 | $8 | $23 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
479 | $12 | $48 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
389 | $6 | $14 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
256 | $26 | $102 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
233 | $106 | $422 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
229 | $58 | $227 |
| Anti-nausea injection (ondansetron/Zofran) | 220 | $0 | $0 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
216 | $116 | $469 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
166 | $2 | $8 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
99 | $1 | $6 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
91 | $132 | $548 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
87 | $19 | $70 |
| Injection, fosnetupitant 235 mg and palonosetron 0.25 mg | 76 | $331 | $1,539 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
66 | $13 | $55 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
65 | $1 | $3 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
65 | $1 | $4 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
63 | $63 | $264 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
59 | $59 | $231 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
56 | $24 | $99 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
50 | $30 | $116 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
38 | $12 | $44 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
38 | $0 | $8 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
30 | $141 | $593 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
29 | $30 | $114 |
| New patient office visit, complex (60-74 min) | 13 | $185 | $725 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
72.5% high complexity
25.0% medium
2.4% routine
Industry Payment Transparency
Open Payments through 2024 ↗$3,465
Total received (2018-2024)
Avg $495/year across 7 years
Top 48% in NJ for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
50
Companies
145
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$658
2023
$1,039
2022
$176
2021
$304
2020
$216
2019
$777
2018
$295
Payments by company (2024)
GlaxoSmithKline, LLC.
$143
Bayer Healthcare Pharmaceuticals Inc.
$63
Mirati Therapeutics, Inc.
$55
Aveo Pharmaceuticals, Inc.
$36
Takeda Pharmaceuticals U.S.A., Inc.
$30
PFIZER INC.
$29
Dendreon Pharmaceuticals LLC
$28
Stemline Therapeutics Inc.
$22
Novartis Pharmaceuticals Corporation
$21
ARRAY BIOPHARMA INC
$21
Pharmacosmos Therapeutics Inc.
$20
Apellis Pharmaceuticals, Inc.
$20
TAIHO ONCOLOGY, INC.
$19
Janssen Biotech, Inc.
$19
Merck Sharp & Dohme LLC
$18
PUMA BIOTECHNOLOGY, INC.
$18
Regeneron Healthcare Solutions, Inc.
$17
Boehringer Ingelheim Pharmaceuticals, Inc.
$17
Astellas Pharma US Inc
$17
Blueprint Medicines Corporation
$16
E.R. Squibb & Sons, L.L.C.
$15
Celgene Corporation
$14
Top 3 companies account for 39.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$267
AstraZeneca Pharmaceuticals LP
$250
Celgene Corporation
$241
E.R. Squibb & Sons, L.L.C.
$196
GlaxoSmithKline, LLC.
$194
Covidien LP
$137
ABBVIE INC.
$124
Genentech USA, Inc.
$124
Astellas Pharma US Inc
$120
PFIZER INC.
$112
Kite Pharma, Inc.
$104
Gilead Sciences, Inc.
$102
Amgen Inc.
$98
Daiichi Sankyo Inc.
$95
Bayer Healthcare Pharmaceuticals Inc.
$90
Incyte Corporation
$80
Mirati Therapeutics, Inc.
$77
Merck Sharp & Dohme LLC
$70
Takeda Pharmaceuticals U.S.A., Inc.
$67
Janssen Biotech, Inc.
$64
Pharmacosmos Therapeutics Inc.
$62
Alexion Pharmaceuticals, Inc.
$53
GENZYME CORPORATION
$52
Bayer HealthCare Pharmaceuticals Inc.
$48
Janssen Scientific Affairs, LLC
$47
EMD Serono, Inc.
$46
ADC Therapeutics America, Inc.
$42
Aveo Pharmaceuticals, Inc.
$36
Eisai Inc.
$35
Agios Pharmaceuticals, Inc.
$35
Boehringer Ingelheim Pharmaceuticals, Inc.
$31
Blueprint Medicines Corporation
$30
Seattle Genetics, Inc.
$29
Dendreon Pharmaceuticals LLC
$28
Verastem, Inc.
$24
CTI BioPharma Corp.
$23
Stemline Therapeutics Inc.
$22
ARRAY BIOPHARMA INC
$21
Apellis Pharmaceuticals, Inc.
$20
TAIHO ONCOLOGY, INC.
$19
PUMA BIOTECHNOLOGY, INC.
$18
Regeneron Healthcare Solutions, Inc.
$17
Sumitomo Pharma America, Inc.
$16
Puma Biotechnology, Inc.
$16
Genmab U.S., Inc.
$16
Clovis Oncology, Inc.
$15
AbbVie, Inc.
$14
Mitsubishi Tanabe Pharma America, Inc.
$13
Merck Sharp & Dohme Corporation
$13
Karyopharm Therapeutics Inc.
$12
Top 3 companies account for 21.9% of all-time payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AYVAKIT · Aliqopa · BAVENCIO · BLENREP · BOSULIF · Bavencio · CALQUENCE · COSELA · Columvi · Copiktra · DARZALEX · ELREXFIO · EMPLICITI · ENHERTU · EPKINLY · Empaveli · Enhertu · Epkinly · Erleada · FOTIVDA · GILOTRIF · IBRANCE · IMBRUVICA · INJECTAFER · INLYTA · JAKAFI · JEMPERLI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · LIBTAYO · LONSURF · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONOFERRIC · NINLARO · Nubeqa · OJJAARA · OPDIVO · ORGOVYX · OXBRYTA · Orserdu · PIQRAY · PROVENGE · PYRUKYND · Padcev · Phesgo · Pomalyst · REBLOZYL · Radicava · Revlimid · Rubraca · SCEMBLIX · SIMPONI ARIA · SPRYCEL · Stivarga · TASIGNA · TECENTRIQ · Tecentriq · Trodelvy · Ultomiris · VENCLEXTA · Venclexta · Vitrakvi · Vonjo · XOSPATA · XPOVIO · XTANDI · Xospata · Xtandi · Yescarta · ZEJULA · superDimension
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematology & oncology specialists in nearby ZIP areas
186
County median income
$135,960
Nearest hospital to ZIP centroid (approximate)
UNIVERSITY BEHAVIORAL HEALTH CARE
4.6 mi
4.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | — Not enrolled | N/A |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Porcelli is a mixed practice specialist, with above-average Medicare volume (top 6% in NJ), with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Porcelli experienced with iron infusion (injectafer)?
Based on Medicare claims data, Dr. Porcelli performed 85,500 iron infusion (injectafer) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Porcelli receive payments from pharmaceutical companies?
Yes. Dr. Porcelli received a total of $3,465 from 50 companies across 145 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Porcelli's costs compare to other hematology & oncology specialists in Somerset?
Dr. Porcelli's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Porcelli) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Somerset
Browse hematology & oncology specialists in Somerset ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in NJ
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in NJ
Which NJ hematology & oncology specialists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Celgene Corporation Payments to Doctors
See all physicians who received payments from Celgene Corporation.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology